German Pharma Supplier Building $371M NC Plant

German syringe maker Schott Pharma is going ahead with a $371 million manufacturing plant in Wilson, North Carolina, 50 miles east of Raleigh. The investment will add over 400 jobs to the region.

The new site will expand the U.S. supply chain for in-demand syringes that deliver injectable medicines, vaccines, and other fields of applications, allowing SCHOTT Pharma to triple its contribution of glass and polymer syringes to the U.S. market by 2030.

Schott’s Christopher Cassidy added, “Wilson County stood out in a nationwide search for a number of reasons, particularly for its favorable pool of local talent and its proximity to the Research Triangle area, which hosts numerous universities, healthcare companies, and biopharma resources.” North Carolina supported SCHOTT’s expansion with $21 million in local and state incentive awards.

The project is expected to break ground by the end of the year, with a completion date sometime in 2027.